AUG 11, 2016 7:29 AM PDT

A New Case for Why Heart Cancer is Rare

WRITTEN BY: Xuan Pham
In 2014 the most common cancer diagnosis was breast cancer, followed by prostate, lung, colon, skin, and brain cancer. By contrast, the Mayo clinic estimated that leading hospitals around the country see less than one case of heart cancer every year. The reason for this could be due to natural selection putting severe pressure on this organ, as purported by researchers in the latest Opinion piece published in Trends in Cancer.

Natural selection protects the heart from cancer? | Image: pixabay.com
 
"The organs that are the most important to keeping you alive and capable of reproduction, such as the heart, brain, or uterus, may enjoy a better protection against cancer, all other things being equal," said Frédéric Thomas, who is an evolutionary biologist at the Center for Ecological and Evolutionary Cancer Research in France.
 
This evolution-based idea is in line with what we already know about the cell biology of the heart and cancer. For example, we know risks for cancer increases with more cycles of cell division, which is relatively low for heart cells. Unlike skin or colon cells that are constantly dividing and shedding, heart cells don’t usually participate in this renewal process (unless there’s been damages). With such few cell divisions, heart cells have very small chances of accumulating enough mutations to become cancerous.

Heart cancer is also thought to be rare because the heart doesn’t get exposed to too many external carcinogens, other than those found in blood. This also significantly lowers the mutation rate of heart cells. Thomas argues that evolutionary selection is behind the protection that seemingly surrounds the heart and other vital organs that don’t come in pairs.
 
"Organs that are large or in pairs could potentially accumulate larger numbers of oncogenic manifestations without being impaired, whereas small and important organs like the pancreas could be easily compromised with only a few tumors inside," said Thomas. Very simply speaking, these single organs have a very high protection against mutations because there just isn’t another backup copy.
 
This hypothesis seems to be consistent with the heart and cancer. However, it doesn’t seem to explain why cancer incidences are much higher in other single vital organs like the pancreas and brain. In response, Thomas said, “"We are not saying that this is the main factor to explain the different susceptibility of organs to cancer, but it is a factor that contributes with others."
 
Though rare, heart cancer is possible, and it usually involves cancer from other nearby organs like the breast, kidney, and lung. Elsewhere in the body, cancer can also migrate large distances to affect the heart. And while the chances of getting heart cancer is low, we still need to remember to take good care of this vital organ because heart disease is still among one of the biggest killers for adults.
 

Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
OCT 25, 2020
Cell & Molecular Biology
Revealing More About the Genetics of Ewing Sarcoma
OCT 25, 2020
Revealing More About the Genetics of Ewing Sarcoma
Ewing sarcoma is a rare kind of cancer that tends to impact young people and occurs in bones or the tissue around them. ...
OCT 27, 2020
Cancer
Increased muscle mass improves outcomes for colorectal cancer surgery
OCT 27, 2020
Increased muscle mass improves outcomes for colorectal cancer surgery
New research published in JAMA Surgery reports a new way to prepare for surgery: sit-ups. According to the findings ...
NOV 04, 2020
Cancer
Building a New Chemotherapy Drug
NOV 04, 2020
Building a New Chemotherapy Drug
For decades, modern medicine has relied on chemists’ work to produce compounds that could one day be used as a dru ...
NOV 07, 2020
Cancer
Newly identified biomarker sheds light on antiangiogenic drug responses
NOV 07, 2020
Newly identified biomarker sheds light on antiangiogenic drug responses
A study published last week in the journal EMBO Molecular Medicine provides insight into the molecular mechanisms t ...
Loading Comments...